Tuesday, June 6, 2017
- 1:45pm-3:15pm
-
Tardive syndromes induced by coadministration of tramadol and sertralin
Drug-Induced Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Targeted overexpression of A53T-alpha-synuclein induces progressive neurodegeneration and electrophysiological changes of noradrenergic locus coeruleus neurons – a preclinical model of Parkinson’s disease
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Targeting alpha-Synuclein Aggregation for the Treatment of Parkinson’s Disease
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.
Tremor · Exhibit Hall C
- 1:45pm-3:15pm
-
The Accreditation and Certification of the Movement Disorders Subspecialty
Education in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
The AppTUG : a new application for analyzing the Timed Up and Go task in patients with neurological disorders
Technology · Exhibit Hall C
- 1:45pm-3:15pm
-
The comparison of urine microvesicle reflecting gut microbiome between Parkinson’s disease and healthy control
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
The effects of dual task on the finger tapping performance of Parkinson’s disease.
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
The Huntington’s Disease Health Index Study (HD-HI)
Huntington's Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
The influence of neurorehabilitation on Parkinson medication
Therapy in Movement Disorders · Exhibit Hall C
- «Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 38
- Next Page»